Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Miaomiao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation…. Hauptthemen laut MEDLINE: HIV-1, Anti-HIV Agents, HIV Infections, HIV Seropositivity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Ministry of Science and Technology's, Key R&D Program of China, State Key Laboratory for Infectious Disease Prevention and Control of China.
Abstract (Originalsprache)
Objectives
To assess the impact of pretreatment low-abundance HIV drug-resistant variants (LA-DRVs) on virological outcomes among ART-naive HIV-1-infected Chinese people who initiated ART.
Methods
A nested case–control study was conducted among HIV-1-infected individuals who had pretreatment drug resistance (PDR) genotypic results. Cases were defined as individuals with virological failure (HIV-1 RNA viral load ≥1000 copies/mL) after 1 year of ART, and controls were individuals from the same cohort whose viral load was less than 1000 copies/mL. Next-generation sequencing was used to identify low-abundance PDR mutations at detection thresholds of 10%, 2% and 1%. The mutant load was calculated by multiplying the abundance of HIV-1 drug-resistant variants by the pretreatment viral load. The impact of pretreatment low-abundance mutations on virological failure was estimated in logistic regression models.
Results
Participants (43 cases and 100 controls) were included in this study for the analysis. The proportion of participants with PDR was higher in cases than in controls at different detection thresholds (44.2% versus 22.0%, P = 0.007 at 10% threshold; 58.1% versus 31.0%, P = 0.002 at 2% threshold; 90.7% versus 69.0%, P = 0.006 at 1% threshold). Compared with participants without PDR, participants with ≥10% detectable PDR mutations were associated with an increased risk of virological failure (adjusted OR 8.0, 95% CI 2.4–26.3, P = 0.001). Besides this, individuals with pretreatment LA-DRVs (2%–9% abundance range) had 5-fold higher odds of virological failure (adjusted OR 5.0, 95% CI 1.3–19.6, P = 0.021). Furthermore, LA-DRVs at 2%–9% abundance resistant to NRTIs and mutants with abundance of ≥10% resistant to NNRTIs had a 4-fold and 8-fold risk of experiencing virological failure, respectively. It was also found that a mutant load of more than 1000 copies/mL was predictive of virological failure (adjusted OR 7.2, 95% CI 2.5–21.1, P = 0.0003).
Conclusions
Low-abundance PDR mutations ranging from 2% to 9% of abundance can increase the risk of virological failure. Further studies are warranted to define a clinically relevant threshold of LA-DRVs and the role of NRTI LA-DRVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing 10…
ORCID-Profile: Yiming Shao
Förderung
- Ministry of Science and Technology's
- Key R&D Program of China
- State Key Laboratory for Infectious Disease Prevention and Control of China
Zitieren
APA
Li, M., Song, C., Hu, J., Dong, A., Kang, R., Feng, Y., Xing, H., Ruan, Y., Shao, Y., Hong, K., & Liao, L. (2023). Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad297
Vancouver
Li M, Song C, Hu J, Dong A, Kang R, Feng Y, et al. Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad297
BibTeX
@article{Li2023,
author = {Li, Miaomiao and Song, Chang and Hu, Jing and Dong, Aobo and Kang, Ruihua and Feng, Yi and Xing, Hui and Ruan, Yuhua and Shao, Yiming and Hong, Kunxue and Liao, Lingjie},
title = {Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad297}
}
EUVIMED